Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
Status:
ENROLLING_BY_INVITATION
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical study has two objectives. The Primary Objective is to evaluate the effectiveness of microdosed GLP-1 receptor agonists in improving measures of health, quality of life, and longevity. The Secondary Objective: To assess the impact of these therapies on weight management practices and metabolic health.